Recently, Trp depletion and KYN metabolites generation were identified in plasma of GC through disease progression within the Correa’s cascade [27], and enhanced KYN level in serum has been showed to facilitate Treg induction in vitro to promote chemotherapy resistance in gastric cancer cells through IL-10/STAT3/BCL2 [28]. This evidence concerns the gene BCL2 and gastric cancer.